Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation may be beneficial in the treatment of several psychiatric disorders, including depression. A small number of studies have suggested that there may also be cognitive and mood effects in healthy samples. The purpose of the present study was to investigate the effects of n-3 PUFA on depression-relevant cognitive functioning in healthy individuals. Fifty-four healthy university students were randomized to receive either n-3 PUFA supplements or placebo for 4 weeks in a double-blind design. The test battery included measures of cognitive reactivity, attention, response inhibition, facial emotion recognition, memory and risky decision-making. Results showed few effects of n-3 PUFAs on cognition and mood states. The n-3 PUFA group made fewer risk-averse decisions than the placebo group. This difference appeared only in non-normative trials of the decision-making test, and was not accompanied by increased impulsiveness. N-3 PUFAs improved scores on the control/perfectionism scale of the cognitive reactivity measure. No effects were found on the other cognitive tasks and no consistent effects on mood were observed. The present findings indicate that n-3 PUFA supplementation may have a selective effect on risky decision making in healthy volunteers, which is unrelated to impulsiveness.
Appleton KM Hayward RC Gunnell D Peters TJ Rogers PJ Kessler D (2007) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr84: 1308–1316.
2.
Attenburrow MJ Williams C Odontiadis J Reed A Powell J Cowen PJ (2003) Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology169: 104–107.
3.
Austin MP Mitchell P Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry178: 200–206.
4.
Beck AT Steer RA Garbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev8: 77–100.
5.
Booij L Van der Does AJW (2007) Cognitive and serotonergic vulnerability to depression: convergent findings. J Abnorm Psychol116: 86–94.
6.
Browning M Reid C Cowen PJ Goodwin GM Harmer CJ (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol21: 684–690.
7.
Carver CS White TL (1994) Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales. J Pers Soc Psychol67: 319–333.
8.
Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids75: 259–269.
9.
De la Presa OS Innis SM (1999) Docosahexaenoic acid and arachidonic acid prevent a decrease in dopaminergic and serotonergic neurotransmitters in frontal cortex caused by a-linoleic and alpha-linolenic acid deficiënt diet in formula-fed piglets. J Nutr129: 2088–2093.
10.
Ekman P Friesen WV (1976) Measuring facial movement. Environ Psychol Nonverbal Behav1: 56–75.
11.
Fontani G Corradeschi F Felici A Alfatti F Migliorini S Lodi L (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest35: 691–699.
12.
Freeman MP (2000) Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry12: 159–165.
13.
Freeman PM Hibbeln JR Wisner KL Davis JM Mischoulon D Peet M Keck PE Marangell LB Richardson AJ Lake J Stoll AL (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry67: 1954–1967.
14.
Hallahan B Garland MR (2004) Essential fatty acids and their role in the treatment of impulsivity. Prostaglandins Leukot Essent Fatty Acids71: 211–216.
15.
Hamazaki T Sawazaki S Kobayashi M (1996) The effect of docasahexaenoic acid on aggression in young adults. A double-blind study. J Clin Invest97: 1129–1134.
16.
Harmer CJ Bhagwagar Z Perrett DI Volm BA Cowen PI Goodwin GM (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology28: 148–152.
17.
Hibbeln JR Linnoila M Umhau JC Rawlings R George DT Salem N (1998) Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects and early- and late-onset alcoholics. Biol Psychiatry44: 235–242.
18.
Hockey RGJ Maule JA Clough PJ Bdzola L (2000) Effects of negative mood states on risk in everyday decision making. Cogn Emot14: 823–855.
19.
Isen AM Geva N (1987) The influence of positive affect on acceptable level of risk and thoughts about losing: The person with a large canoe has a large worry. Organ Behav Hum Decis Process39: 145–154.
20.
Kahneman D Tversky A (1979) Prospect theory: an analysis of decision under risk. Econometrica47: 263–292.
21.
Kodas E Galineau L Bodard S Vancassel S Guilloteau D Besnard J (2004) Serotonergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem89: 695–702.
22.
Lin P-Y Su K-P (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry68: 1056–1061.
23.
McLean A Rubinsztein JS Robbins TW Sahakian BJ (2004) The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology171: 286–297.
24.
McNair DM Lorr M Droppelamn LF (1971) Manual for the Profile of Mood States.San Diego, CA: Educational and Industrial Testing Service.
25.
Merens W Booij L Markus RC Zitman FG Onkenhout W Van der Does AJW (2005) The effects of a tryptophan-enriched diet on mood and cortisol response in unmedicated recovered depressed patients and controls. Br J Nutr94: 415–422.
26.
Merens W Van der Does AJW Spinhoven P (2007) The effects of serotonin manipulations on emotional information processing and mood. J Affect Disord103: 43–62.
27.
Murphy FC Smith KA Cowen PJ Robbins TW Sahakian BJ (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology163: 42–53.
28.
Parker G Gibson NA Brotchie H Heruc G Rees A Hadzi-Pavlovic D (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry163: 969–978.
29.
Riedel WJ Klaasen T Deutz EPN van Someren A van Praag HM (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology141: 362–369.
30.
Rogers RD Lancaster M Wakeley J Bhagwagar Z (2004) Effects of beta-adrenoceptor blockade on components of human-decision making. Psychopharmacology172: 157–164.
31.
Rogers RD Tunbridge EM Bhagwagar Z Drevets WC Sahakian BJ Carter CS (2003) Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology28: 153–162.
32.
Rogers RD Wakeley J Robson PJ Bhagwagar Z Makela P (2007) The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults. Neuropsychopharmacology32: 417–428.
33.
Saan RJ Deelman BG (1986) Nieuwe 15-woorden test A en B (15WTA en 15WTB) [New version of 15 Words Test (15WTA and 15WTB)]. In: Bauma, A, Mulder, J, Lindeboom, J, (eds), Neuro-Psychologische Diagnostiek: Handboek [Neuro-psychological Diagnostics : Handbook]. Lisse: Swets & Zeitlinger Publishers. pp. 13–28.
34.
Scarna A McTavish SFB Cowen PJ Goodwin GM Rogers RD (2005) The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision making. Psychopharmacology179: 761–768.
35.
Schmitt J Jorissen B Sobczak S van Boxtel MPJ Hogervorst E Deutz NEP (2000) Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. Psychopharmacology14: 21–29.
36.
Schneider SL Lopes LL (1986) Reflection in preference under risk: who and when may suggest why. J Exp Psychol Hum Percept Perform12: 535–548.
37.
38.
Sheehan DV Lecrubier Y Harnett-Sheehan K Amorim P Janavs J Weiller E (1998) The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry59: 22–33.
39.
Van der Does AJW (2002a) Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther40: 105–120.
40.
Van der Does AJW (2002b) Handleiding bij de Nederlandse bewerking van de BDI-II. San Antonio, Texas/Amsterdam, The Netherlands: The Psychological Corporation/Harcourt Publishers.
41.
42.
Wald FDM Mellenbergh GJ (1990) De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Ned Tijdschr Psychol45: 86–90.
43.
Wood RM Rilling JK Sanfey AG Bhagwagar Z Rogers RD (2006) Effects of tryptophan depletion on the performance of an iterated Prisoner’s Dilemma game in healthy adults. Neuropsychopharmacology31: 1075–1084.
44.
Yehuda S Rabinovitz S Mostofsky DI (1999) Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res56: 565–570.
45.
Young G Conquer J (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev45: 1–28.
